C4 Therapeutics to Present at Upcoming Investor Conferences
C4 Therapeutics, Inc. (Nasdaq: CCCC) announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
C4 Therapeutics, Inc. (Nasdaq: CCCC) announced its participation in two upcoming investor conferences. The first is the UBS Global Healthcare Conference on May 26, 2021, at 8:00 a.m. ET, followed by the Jefferies Healthcare Conference on June 1, 2021, at 10:30 a.m. ET. Live webcasts will be available on the company’s website, with replays archived for two weeks post-event. C4 Therapeutics focuses on developing small-molecule medicines that selectively degrade disease-causing proteins, offering a novel approach to treating cancer and other diseases.
Details
News Market Reaction – CCCC
The recorded move for CCCC in the trading session of this news was -1.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the Company will participate in the following upcoming investor conferences:
- UBS Global Healthcare Conference on Wednesday, May 26, 2021 at 8:00 a.m. ET
- Jefferies Healthcare Conference on Tuesday, June 1, 2021 at 10:30 a.m. ET
A live webcast of each event can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.c4therapeutics.com. Replays of the webcasts will be archived on the C4T website for at least two weeks following the applicable presentation date.
About C4 Therapeutics
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity. To learn more about C4 Therapeutics, visit www.C4Therapeutics.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.